ID: ALA329399
Chembl Id: CHEMBL329399
PubChem CID: 44325112
Max Phase: Preclinical
Molecular Formula: C14H14O3S
Molecular Weight: 262.33
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC1=C(SCCCO)C(=O)c2ccccc2C1=O
Standard InChI: InChI=1S/C14H14O3S/c1-9-12(16)10-5-2-3-6-11(10)13(17)14(9)18-8-4-7-15/h2-3,5-6,15H,4,7-8H2,1H3
Standard InChI Key: UNNZADUMTZMIOQ-UHFFFAOYSA-N
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Molecular Weight: 262.33 | Molecular Weight (Monoisotopic): 262.0664 | AlogP: 2.46 | #Rotatable Bonds: 4 |
| Polar Surface Area: 54.37 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
| #RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
| CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 1.54 | CX LogD: 1.54 |
| Aromatic Rings: 1 | Heavy Atoms: 18 | QED Weighted: 0.85 | Np Likeness Score: 0.16 |
| 1. Chen C, Liu YZ, Shia KS, Tseng HY.. (2002) Synthesis and anticancer evaluation of vitamin K(3) analogues., 12 (19): [PMID:12217364] [10.1016/s0960-894x(02)00532-2] |
Source(1):
